arrow
Y

Ying Hong

daiichi sankyo company limited
H指数:45
被引数:6,723

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exposure-Response Analyses of Datopotamab Deruxtecan (Dato-DXd) in Patients with Hormone Receptor (HR) Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

Datopotamab Deruxtecan(Dato-DXd)在激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性乳腺癌患者中的暴露-反应分析

2026-04-160
OAAI
Optimal Dosage Justification for Datopotamab Deruxtecan in HR-Positive/HER2-Negative Breast Cancer Through Model-Informed Drug Development Approaches

通过模型指导的药物开发方法对datopotamab deruxtecan在HR阳性/HER2阴性乳腺癌中的最佳剂量进行合理性论证

2026-02-152
OAAI
Population Pharmacokinetic Analysis of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

达波替单抗德鲁克坦(Dato-DXd)的群体药代动力学分析,该药是一种TROP2靶向抗体药物偶联物,用于治疗晚期实体瘤患者。

2025-10-010
OAAI
Gut microbiota-brain bile acid axis orchestrates aging-related neuroinflammation and behavior impairment in mice

肠道菌群-脑胆汁酸轴协调小鼠衰老相关的神经炎症和行为障碍

2024-10-011
OAAI